117 results
Page 2 of 6
6-K
EX-99
gs6cyxlc1hx9xut
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
6spi9y6
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
7nqq2ebj04g8 9py1
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
w9twszxnf38ihjl7
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-99.1
flhntd5 vby
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99
dyh4htr5
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
6-K
EX-99
mwwdk6vym
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
EX-99
h4tsc r00s5v49y
22 Oct 18
Current report (foreign)
7:00am
6-K
EX-99
c3c0w1dx7jg1n rc
19 Oct 18
BioLineRx Presents Top-Line Results from
7:00am
6-K
EX-10.3
by0tute67qyva
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99.1
dhm4zqbex2f8yklekv
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
q9r0jdh oqr
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
6-K
EX-99
94ju4zqgrwvlxmlz8
18 Jun 18
BioLineRx Presents New Overall Survival Data from
7:00am
6-K
EX-99
xwh1m
17 May 18
BioLineRx to Present Overall Survival Data at EHA from
9:12am
6-K
EX-99
3kcodp dhy
17 May 18
BioLineRx Reports Results of Phase 2 Study
8:57am
6-K
EX-99
gptp3jm7j4uo epzxk1
16 May 18
BioLineRx Announces Grant of European Patent
6:58am
6-K
EX-99
nm5bcqm
18 Oct 17
BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040
12:00am